In a new study from Cleveland Clinic, researchers found people with metabolic syndrome have much worse hospitalization and mortality rates due to COVID-19.
They found that patients with metabolic syndrome were 77% more likely to be hospitalized, 56% more likely to be admitted to the intensive care unit, and 81% more likely to die from COVID-19.
Hypertension, diabetes, and obesity are common comorbidities linked to metabolic syndrome.
Reducing symptoms of metabolic syndrome could help reduce morbidity and mortality of COVID-19, the team says.
Researchers say that this study is a timely reminder of the need to appreciate individual risk factors when assessing outcomes of COVID-19—and that obesity is probably the most important (and modifiable) risk factor that explains the increase in risk.
For example, the presence of metabolic syndrome doubled the death rate from 3% to 6%.
Half of all patients with metabolic syndrome were hospitalized—in contrast to 25% of those without metabolic syndrome.
If you care about COVID, please read studies about drug that is effective in treating severe COVID-19, and antibody drug that could reduce death risk in severe COVID-19.
For more information about health, please see recent studies about why COVID-19 can trigger severe disease and death, and results showing COVID-19 vaccine booster could effectively protect those 60 and older.
The study is published in Metabolic Syndrome and Related Disorders. One author of the study is Sangeeta Kashyap, MD.
Copyright © 2022 Knowridge Science Report. All rights reserved.
